您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2025, Vol. 63 ›› Issue (4): 19-25.doi: 10.6040/j.issn.1671-7554.0.2024.0895

• 营养、肠道微生态及相关疾病 • 上一篇    

人体成分与代谢相关脂肪性肝病的相关性:一项横断面研究

武海环1,王龙龙2,赵丽1,张冰1,牟亚楠1,张鸽1,孙春华1   

  1. 1.山东大学齐鲁医院健康管理中心, 山东 济南 250012;2.齐鲁师范学院体育学院, 山东 济南 250200
  • 发布日期:2025-04-08
  • 通讯作者: 孙春华. E-mail:965591989@qq.com
  • 基金资助:
    山东省社会科学规划研究项目(22CTYJ10)

Relationship between body composition and metabolic associated fatty liver disease: a cross-sectional analysis

WU Haihuan1, WANG Longlong2, ZHAO Li1, ZHANG Bing1, MU Yanan1, ZHANG Ge1, SUN Chunhua1   

  1. 1. Department of Health Management Center, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Physical Education Institute, Qilu Normal University, Jinan 250200, Shandong, China
  • Published:2025-04-08

PDF (PC)

208

摘要： 目的 探讨健康体检人群人体成分与代谢相关脂肪性肝病(metabolic associated fatty liver disease, MAFLD)的关联,为MAFLD的早期预防、早期筛查以及健康干预提供理论依据。 方法 采用横断面调查研究方法,选取2021年4月至2022年4月的健康体检人员4 046例,依据检查结果将研究对象分为MAFLD组(n=1 347例)和非MAFLD组(n=2 699例),比较两组一般资料、人体成分、实验室检查的差异,并采用二元Logistic 回归模型分析影响MAFLD的独立危险因素。 结果 MAFLD患病率为33.29%(1 347/4 046),高血压、饮酒、年龄偏大、超重、有中心型肥胖的人群MAFLD的患病率较高,差异均具有统计学意义(P<0.05)。MAFLD组的体质量指数(body mass index, BMI)、体脂率(percent body fat, PBF)、腰臀比(waist-to-hip ratio, WHR)、内脏脂肪面积(visceral fat area, VFA)、上臂围(arm circumference, AC)、体质量、肝功能、血脂、血糖、血压数值均明显高于非MAFLD组,差异均具有统计学意义(P<0.05)。二元Logistic 回归分析得出,VFA(OR=1.010, 95%CI: 1.006~1.014, P<0.001)、TG(OR=2.049, 95%CI: 1.841~2.279, P<0.001)、AC(OR=1.387, 95%CI: 1.327~1.449, P<0.001)、WHR(OR=37.925, 95%CI: 2.866~501.899, P=0.006)、PBF(OR=1.239, 95%CI:1.091~1.408, P=0.001)是MAFLD的独立影响因素。 结论 人体成分分析中的PBF、WHR、VFA、AC与MAFLD具有一定相关性。监测人体成分的变化,减少WHR、降低PBF和VFA,积极控制血脂,对预防MAFLD有重要作用。

关键词: 人体成分, 代谢相关脂肪性肝病, 体脂率, 腰臀比, 内脏脂肪面积, 上臂围

Abstract: Objective To explore the association and risk factors between body composition and metabolic associated fatty liver disease(MAFLD), and to provide a theoretical basis for early prevention, screening and intervention of MAFLD. Methods A total of 4,046 healthy physical examiners were selected from April 2021 to April 2022, and the subjects were divided into MAFLD group(n=1,347)and non-MAFLD group(n=2,699)according to the examination results. The differences of general information, body composition and laboratory indices between the two groups were compared. Binary Logistic regression model was used to analyze the independent risk factors for MAFLD. Results The prevalence of MAFLD was 33.29%(1,347/4,046). The prevalence of MAFLD was higher in patients with hypertension, alcohol drinking, older age, overweight and abdominal obesity, with statistical significance(P<0.05). The values of body mass index(BMI), percent body fat(PBF), waist-to-hip ratio(WHR), visceral fat area(VFA), arm circumference(AC), weight, liver function, blood lipid, fasting blood glucose and blood pressure in the MAFLD group were significantly higher than those in the non-MAFLD group, with statistical significance(P<0.05). Binary Logistic regression analysis showed that VFA(OR=1.010, 95%CI:1.006-1.014, P<0.001), PBF(OR=1.239, 95%CI:1.091-1.408, P=0.001), WHR(OR=37.925, 95%CI: 2.866-501.899, P=0.006), AC(OR=1.387, 95%CI:1.327-1.449, P<0.001), TG(OR=2.049, 95%CI:1.841-2.279, P<0.001)were independent influencing factors of MAFLD. Conclusion PBF, WHR, VFA, and AC are recognized as independent determinants of MAFLD. Monitoring changes of body composition, reducing WHR, PBF and VFA, and actively controlling fasting blood lipid level are important in the prevention of MAFLD.

Key words: Body composition, Metabolic associated fatty liver disease, Percent body fat, Waist-to-hip ratio, Visceral fat area, Arm circumference

中图分类号: 

  • R575.5
[1] Shiha G, Korenjak M, Eskridge W, et al. Redefining fatty liver disease: an international patient perspective[J]. Lancet Gastroenterol Hepatol, 2021, 6(1): 73-79.
[2] Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement[J]. J Hepatol, 2020, 73(1): 202-209.
[3] Méndez-Sánchez N, Bugianesi E, Gish RG, et al. Global multi-stakeholder endorsement of the MAFLD definition[J]. Lancet Gastroenterol Hepatol, 2022, 7(5): 388-390.
[4] Lukaski HC, Johnson PE, Bolonchuk WW, et al. Assessment of fat-free mass using bioelectrical impedance measurements of the human body[J]. Am J Clin Nutr, 1985, 41(4): 810-817.
[5] Maslennikov R, Ivashkin V, Alieva A, et al. Gut dysbiosis and body composition in cirrhosis[J]. World J Hepatol, 2022, 14(6): 1210-1225.
[6] Carretero-Krug A, úbeda N, Velasco C, et al. Hydration status, body composition, and anxiety status in aeronautical military personnel from Spain: a cross-sectional study[J]. Mil Med Res, 2021, 8(1): 35. doi:10.1186/s40779-021-00327-2
[7] 李倩倩, 魏丽丽, 庞旭峰, 等. 人体成分测量辅助评估血液透析患者液体负荷的效果研究[J]. 中华护理杂志, 2019, 54(6): 812-816. LI Qianqian, WEI Lili, PANG Xufeng, et al. Clinical study of bioelectrical impedance assisted assessment of volume in hemodialysis patients[J]. Chinese Journal of Nursing, 2019, 54(6): 812-816.
[8] 邹凌燕, 赵长峰. 大学生人体成分的测定与分析[J]. 山东大学学报(医学版), 2005, 43(12): 1185-1187. ZOU Lingyan, ZHAO Changfeng. Analysis of body compositions of university students[J]. Journal of Shandong University(Health Sciences), 2005, 43(12): 1185-1187.
[9] 刘婧, 李燕菊, 饶志勇. 非酒精性脂肪性肝病患者FibroScan指标与人体成分指标相关性分析[J]. 中西医结合肝病杂志, 2021, 31(12): 1108-1111. LIU Jing, LI Yanju, RAO Zhiyong. Correlation analysis of FibroScan measurements and body composition measure-ments in patients with nonalcoholic fatty liver disease[J]. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, 2021, 31(12): 1108-1111.
[10] 中华医学会肝病学分会. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J]. 中华肝脏病杂志, 2024, 32(5): 418-434. Chinese Society of Hepatology. Guidelines for the prevention and treatment of metabolic dysfunction-associated(non-alcoholic)fatty liver disease(Version 2024)[J]. Chinese Journal of Hepatology, 2024, 32(5): 418-434.
[11] 中华医学会内分泌学分会. 非酒精性脂肪性肝病与相关代谢紊乱诊疗共识(第二版)[J]. 临床肝胆病杂志, 2018, 34(10): 2103-2108.
[12] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版)[J]. 中华肝脏病杂志, 2018, 26(3): 195-203.
[13] Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]. J Hepatol, 2018, 69(4): 896-904.
[14] Song SJ, Lai JC, Wong GL, et al. Can we use old NAFLD data under the new MASLD definition?[J]. J Hepatol, 2024, 80(2): 54-56.
[15] Zhou JH, Zhou F, Wang WX, et al. Epidemiological features of NAFLD from 1999 to 2018 in China[J]. Hepatology, 2020, 71(5): 1851-1864.
[16] 钟晓婷. 体质指数、内脏脂肪面积和腰臀比异常与非酒精性脂肪性肝病相关性的研究[D]. 沈阳: 中国医科大学, 2021.
[17] 林素兰, 宋江美, 夏慧玲, 等. 腰臀围及体质量指数与非酒精性脂肪肝的关联探讨[J]. 中国实用护理杂志, 2014, 30(27): 48-50. LIN Sulan, SONG Jiangmei, XIA Huiling, et al. Association research of nonalcoholic fatty liver disease with waist, hip circumference and body mass index[J]. Chinese Journal of Practical Nursing, 2014, 30(27): 48-50.
[18] 刘佳秋, 陈小芳, 罗国金, 等. 彭州市居民的肥胖患病率分析[J]. 现代预防医学, 2016, 43(15): 2770-2773. LIU Jiaqiu, CHEN Xiaofang, LUO Guojin, et al. Prevalence of obesity among residents in Pengzhou City[J]. Modern Preventive Medicine, 2016, 43(15): 2770-2773.
[19] 刘莹莹, 刘玉萍, 刘佑韧, 等. 代谢相关脂肪性肝病患者有氧运动干预实施的前瞻性研究[J]. 临床肝胆病杂志, 2020, 36(11): 2467-2472. LIU Yingying, LIU Yuping, LIU Youren, et al. Implementation of aerobic exercise intervention in patients with metabolic associated fatty liver disease: a prospective study[J]. Journal of Clinical Hepatology, 2020, 36(11): 2467-2472.
[20] Machado MV. Aerobic exercise in the management of metabolic dysfunction associated fatty liver disease[J]. Diabetes Metab Syndr Obes, 2021, 14: 3627-3645. doi:10.2147/DMSO.S304357
[21] 尚喜雨, 刘荣志, 徐飞. 绝经女性非酒精性脂肪性肝病患病率与体成分关系的初步探讨[J]. 信阳师范学院学报(自然科学版), 2018, 31(3): 415-420. SHANG Xiyu, LIU Rongzhi, XU Fei. Preliminary study of the prevalence of nonalcoholic fatty liver disease and the body composition in menopause women[J]. Journal of Xinyang Normal University(Natural Science Edition), 2018, 31(3): 415-420.
[22] Lukaski HC, Bolonchuk WW, Hall CB, et al. Validation of tetrapolar bioelectrical impedance method to assess human body composition[J]. J Appl Physiol, 1986, 60(4): 1327-1332.
[23] Khan S, Xanthakos SA, Hornung L, et al. Relative accuracy of bioelectrical impedance analysis for assessing body composition in children with severe obesity[J]. J Pediatr Gastroenterol Nutr, 2020, 70(6): 129-135.
[24] Janssen I, Heymsfield SB, Baumgartner RN, et al. Estimation of skeletal muscle mass by bioelectrical impedance analysis[J]. J Appl Physiol, 2000, 89(2): 465-471.
[25] 侯欣彤. 应用生物电阻抗分析评估新诊断甲状腺功能亢进症患者腹部脂肪分布[D]. 太原: 山西医科大学, 2023.
[26] 李妍, 钟仁明, 石磊, 等. 人体成分分析在围放疗期头颈部肿瘤患者中的应用[J]. 肿瘤代谢与营养电子杂志, 2023, 10(6): 758-764. LI Yan, ZHONG Renming, SHI Lei, et al. Application of body composition analysis in head and neck tumors patients through the peri-radiation period[J]. Electronic Journal of Metabolism and Nutrition of Cancer, 2023, 10(6): 758-764.
[27] 孙琦, 陶静, 华建武, 等. 生物电阻抗法在血液透析患者营养状况评估中的应用[J]. 实用临床医药杂志, 2020, 24(13): 4-8. SUN Qi, TAO Jing, HUA Jianwu, et al. Application of bioelectrical impedance analysis in nutritional assessment of patients with hemodialysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(13): 4-8.
[28] 尹镛声. 大学生身体活动水平与身体成分、饮食行为的关系研究[D]. 秦皇岛: 河北科技师范学院, 2023.
[29] 王敬军. 血清TG、TC、ALT及AST检测诊断脂肪肝的临床价值分析[J]. 吉林医学, 2020, 41(5): 1090-1091.
[1] 郭鑫,孟君,郑世良,董秀红. 老年胃癌患者衰弱与人体成分的相关性[J]. 山东大学学报 (医学版), 2024, 62(4): 40-47.
[2] 孙雅文1，高优美1，唐芳2，薛付忠1，张成琪2，于红霞1. 济南市健康体检女性膳食模式与测量指标的相关性[J]. 山东大学学报(医学版), 2013, 51(11): 98-101.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发